Long-lasting response to nivolumab for a patient with lynch syndrome-associated lung adenocarcinoma

Keita Masuzawa; Takanori Asakura; Shinnosuke Ikemura; Hiroyuki Yasuda; Ichiro Kawada; Sosuke Takaoka; Yuichiro Hayashi; Takeshi Nakajima; Masami Arai; Koichi Fukunaga; Kenzo Soejima

doi:10.1200/PO.19.00156

Long-lasting response to nivolumab for a patient with lynch syndrome-associated lung adenocarcinoma

Keita Masuzawa, Takanori Asakura, Shinnosuke Ikemura, Hiroyuki Yasuda, Ichiro Kawada, Sosuke Takaoka, Yuichiro Hayashi, Takeshi Nakajima, Masami Arai, Koichi Fukunaga, Kenzo Soejima

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

Original language	English
Pages (from-to)	74-78
Number of pages	5
Journal	JCO Precision Oncology
Volume	3
DOIs	https://doi.org/10.1200/PO.19.00156
Publication status	Published - 2019

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/PO.19.00156

Cite this

@article{21f97efcd2a94cb5a3c7e6886df20389,

title = "Long-lasting response to nivolumab for a patient with lynch syndrome-associated lung adenocarcinoma",

author = "Keita Masuzawa and Takanori Asakura and Shinnosuke Ikemura and Hiroyuki Yasuda and Ichiro Kawada and Sosuke Takaoka and Yuichiro Hayashi and Takeshi Nakajima and Masami Arai and Koichi Fukunaga and Kenzo Soejima",

year = "2019",

doi = "10.1200/PO.19.00156",

language = "English",

volume = "3",

pages = "74--78",

journal = "JCO Precision Oncology",

issn = "2473-4284",

publisher = "American Society of Clinical Oncology",

}

TY - JOUR

T1 - Long-lasting response to nivolumab for a patient with lynch syndrome-associated lung adenocarcinoma

AU - Masuzawa, Keita

AU - Asakura, Takanori

AU - Ikemura, Shinnosuke

AU - Yasuda, Hiroyuki

AU - Kawada, Ichiro

AU - Takaoka, Sosuke

AU - Hayashi, Yuichiro

AU - Nakajima, Takeshi

AU - Arai, Masami

AU - Fukunaga, Koichi

AU - Soejima, Kenzo

PY - 2019

Y1 - 2019

UR - http://www.scopus.com/inward/record.url?scp=85086366282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086366282&partnerID=8YFLogxK

U2 - 10.1200/PO.19.00156

DO - 10.1200/PO.19.00156

M3 - Article

AN - SCOPUS:85086366282

SN - 2473-4284

VL - 3

SP - 74

EP - 78

JO - JCO Precision Oncology

JF - JCO Precision Oncology

ER -

Long-lasting response to nivolumab for a patient with lynch syndrome-associated lung adenocarcinoma

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this